Can echocardiography facilitate decision-making to CRT?

Abstract Introduction Cardiac resynchronization therapy (CRT) remains underused despite its well-established therapeutic effect and clear guidelines. Among various reasons are the lack of referral, the fear of complications and the high therapy cost. The assessment of mechanical dyssynchrony (MD) on echocardiography has been suggested to aid patient selection. In the past, however, several studies have used old markers of MD producing disappointing results and the use of echocardiography for patient selection became discredited. Promising new markers have been developed since and could aid clinical decision-making for CRT. These should, however, first be thoroughly tested and compared to the old markers. Purpose (I) To confirm the relevance of the new markers of MD for survival free of cardiac death and (II) to compare old and new markers of MD for predicting cardiac death within 5 years post-CRT in patients eligible for CRT according the 2021 ESC guidelines. Methods 222 CRT-patients were analysed retrospectively in a multicentre setting. MD was assessed using three old markers: septal-to-posterior wall-motion-delay (SPWMD), left-ventricular-filling-time/cardiac-cycle ratio (LVFT/RR), and intraventricular mechanical delay (IVMD); and three new markers: systolic stretch index (SSI), myocardial work index (MWI), and visual presence of septal flash or apical rocking (SFoAR). For each marker, patients were categorized using previously published cut-offs as “MD present” (Yes) or “MD not present” (No). Log rank tests were performed on Kaplan-Meier curves for survival free of cardiac death. Cox proportional hazards regressions were used to compute the hazard-ratio (HR) for cardiac death within 5 years after implantation. Results Cardiac death occurred in 37 patients (17%). Patients with MD before CRT according to IVMD (p=0.003), SSI (p<0.001), MWI (p<0.001) or SFoAR (p<0.001) had a significantly better survival. The hazard ratios were 0.34 (95% CI, 0.19–0.75) for IVMD, 0.30 (95% CI, 0.15–0.57) for SSI, 0.26 (95% CI, 0.12–0.54) for MWI and, 0.28 (95% CI, 0.14–0.53) for SFoAR. The other markers for MD were not significant for survival. Conclusion The new markers for dyssynchrony are better than the old. Patients with mechanical dyssynchrony on echocardiography before CRT according to SSI, MWI or SFoAR are 3 to 4 times less likely to die within 5 years after CRT implantation. The presence of one of these markers in patients with a broad QRS (≥130ms) and reduced LVEF (≤35%) should prompt clinicians to refer for or to proceed to CRT. Funding Acknowledgement Type of funding sources: None.